到 2027 年美国复合药房市场预测 - 按产品（口服药物、外用药物、栓剂等）和治疗领域（止痛药物、激素替代疗法、皮肤科应用等）划分的 COVID-19 影响和国家分析
No. of Pages: 111 | Report Code: TIPRE00019845 | Category: Life Sciences
No. of Pages: 111 | Report Code: TIPRE00019845 | Category: Life Sciences
市场介绍
美国复方药房市场，传统复方药房的经营缺乏监管美国FDA。州药房委员会致力于对传统配药（也称为“境内”配药）的监管。复方药房。美国药典 (USP) 为大多数州的药物配制实践制定了标准。美国复方药店通过五个主要渠道运营：独立商店、医院复方部门、大型零售药品制造商连锁店的一部分、具有在线订单交付系统的商店以及多地点商店。在美国，复方药店主要以独立商店形式存在。
市场概况和动态
美国复合药房市场预计将从 2019 年的 30.7964 亿美元增至 2027 年的 50.6956 亿美元。预计 2020 年至 2027 年该市场将以 6.5% 的复合年增长率增长。推动市场的因素包括美国的药物短缺危机以及与复合药物相关的好处。然而，产品召回和严格的监管要求可能会阻碍预测期内的市场增长。
关键细分市场
从产品来看，2019年口服药物细分市场占据最大份额；然而，预计外用药物领域在预测期内将达到市场上最高的复合年增长率。就治疗领域而言，止痛药细分市场在 2019 年占据最大份额，预计该细分市场在预测期内将占据最大市场份额。
主要来源
药房配制联盟、医院配制者短缺药物来源、国际配制药剂师学院、国家健康服务、 全国专业药房协会和世界卫生组织是报告中包含的美国复合药房市场的主要一手和二手来源。
购买报告的理由
美国复合药房市场细分
按产品
按治疗领域< /strong>
公司简介
Strategic insights for US Compounding Pharmacies involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 3,079.64 Million |
| Market Size by 2027 | US$ 5,069.56 Million |
| Global CAGR (2020 - 2027) | 6.5% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 美国
|
| Market leaders and key company profiles |
The regional scope of US Compounding Pharmacies refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - US Compounding Pharmacies Market
The US Compounding Pharmacies Market is valued at US$ 3,079.64 Million in 2019, it is projected to reach US$ 5,069.56 Million by 2027.
As per our report US Compounding Pharmacies Market, the market size is valued at US$ 3,079.64 Million in 2019, projecting it to reach US$ 5,069.56 Million by 2027. This translates to a CAGR of approximately 6.5% during the forecast period.
The US Compounding Pharmacies Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the US Compounding Pharmacies Market report:
The US Compounding Pharmacies Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The US Compounding Pharmacies Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the US Compounding Pharmacies Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For US Compounding Pharmacies Market
